CDK1 and leishmaniasis: The Cyclin-Dependent Kinase1 (CDK1) homologue of Leishmania [cdc2-related protein kinase 3 (LCRK3)] and the glycogen synthase kinase-3short (LGSK-3) have emerged amongst other kinases as putative molecular drug targets for the treatment of leishmaniasis [13,17-20].